A new peptide ligand that targets particles and heterologous proteins to hepatocytes in vivo

Author： Sokoloff A.V.   Wong S.C.   Ludtke J.J.   Sebestyen M.G.   Subbotin V.M.   Zhang G.   Budker T.   Bachhuber M.   Sumita Y.   Wolff J.A.  

Publisher： Elsevier

ISSN： 1525-0016

Source： Molecular Therapy, Vol.8, Iss.6, 2003-12, pp. : 867-872

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Immunodiagnosis of human neurocysticercosis: use of heterologous antigenic particles (Cysticercus longicollis) in indirect immunofluorescence test

By Vaz A.J.   Nakamura P.M.   Barreto C.C.   Ferreira A.W.   Livramento J.A.   Machado A.B.B.  

Serodiagnosis and Immunotherapy in Infectious Disease, Vol. 8, Iss. 3, 1997-01 ,pp. : 157-161

Elsevier

Access to resources Recommend Favorite

Engineered long terminal repeats of retroviral vectors enhance transgene expression in hepatocytes in vitro and in vivo

By Yamaguchi K.   Itoh K.   Ohnishi N.   Itoh Y.   Baum C.   Tsuji T.   Nagao T.   Higashitsuji H.   Okanoue T.   Fujita J.  

Molecular Therapy, Vol. 8, Iss. 5, 2003-11 ,pp. : 796-803

Elsevier

Access to resources Recommend Favorite

New Drug Targets in Rheumatoid Arthritis: Focus on Chemokines

By Shadidi K.R.  

BioDrugs, Vol. 18, Iss. 3, 2004-01 ,pp. : 181-187

Adis International

Access to resources Recommend Favorite

In Vivo Generation of Dendritic Cells by Intramuscular Codelivery of FLT3 Ligand and GM-CSF Plasmids

By Peretz Y.   Zhou Z.F.   Halwani F.   Prud'homme G.J.  

Molecular Therapy, Vol. 6, Iss. 3, 2002-09 ,pp. : 407-414

Elsevier

Access to resources Recommend Favorite

New Targets for Therapy in Polyglutamine (polyQ) Expansion Diseases

By  

Current Drug Therapy, Vol. 3, Iss. 3, 2008-09 ,pp. : 177-189

Bentham Science Publishers

Access to resources Recommend Favorite